Loading…
← CockpitCompetitor Analysis › 2506.HK Xunfei Healthcare Technology Co., Ltd.Open in the cockpit ↗

Xunfei Healthcare Technology Co., Ltd.2506.HKCompetitor analysis, valuation and peers

Hong Kong · HKD·Information Technology›Information Technology Services
Momentum strong 70
Mkt cap
$674M
US dollars, full cap
Free float
12%
of shares outstanding
$/day
$331,908
20-day average traded
Fwd P/E
343.4×
forward earnings
ROIC−WACC
-13.7 pp
WACC 8.9%
Hurdle
n/a
no reverse DCF
Next earnings
134 days
1 Apr 2027
Close · HKDHK$68.95
1D+2.8%
1W-0.5%
1M+4.0%
3M-3.2%
6M-10.4%
YTD-12.8%
1Y-19.2%
ATR %3.9%
52w lowhigh39.9% off high

What Xunfei Healthcare Technology does

Employees: 1,045

Xunfei Healthcare Technology at a glance

Size Xunfei Healthcare Technology (2506.HK) is a Hong Kong Information Technology company (Information Technology Services) with a market value of $674M, the 676th largest of 885 Hong Kong companies the cockpit tracks. Shares closed at HK$68.95 on 18 Nov 2026.

Performance Over six months the shares fell 10.4%, against -11.8% for the median peer and -14.0% for the Hong Kong market (cap-weighted) — 10th highest of 21 in its peer set.

Growth Revenue grew 24.7% over the last twelve months (peer median +6.8%); the operating margin is -7.2% (peer median 1.2%).

Valuation It trades at 343.4× forward earnings against a peer median of 25.9× (most expensive of 12).

Capital Return on invested capital runs 13.7 points below its cost of capital (8.9% WACC).

Next results Next results expected around 1 Apr 2027 (exchange calendar; dates can move).

Relative performance

809010011021 May 202621 Aug 202618 Nov 20262506.HK 87Peer median 84
Six months, rebased to 100: Xunfei Healthcare Technology against the median of its 20 peers (local-currency closes).

Xunfei Healthcare Technology financials

Reported figures in HKD; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
RevenueHK$1.18BHK$992MHK$796MHK$615MHK$549M
Revenue growth—+25%+30%+12%—
Gross profitHK$606MHK$501MHK$459MHK$322MHK$243M
EBITDA-HK$11.3M-HK$73.7M-HK$112M-HK$184M-HK$261M
Net income-HK$57.4M-HK$70.3M-HK$144M-HK$160M-HK$220M
Free cash flow-HK$121M-HK$99.1M-HK$160M-HK$361M-HK$137M
Capital expenditureHK$141MHK$123MHK$35.8MHK$40.3MHK$17.5M
Total debtn/aHK$402MHK$327MHK$141MHK$25.8M

Quarterly statements and history in the cockpit →

Xunfei Healthcare Technology competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-40%-20%0%+20%+40%-20%-10%0%0026426032069959002657301273GFT002279SONATSOFTW6947VRCEBGNG300212000948300465SHF60028830004430028700304044132506.HK6-month return →1-month return →
Up and to the right = strong over both horizons. Xunfei Healthcare Technology is the large dot.

Fundamentals: revenue growth against valuation

-20%0%+20%+40%0×100×200×300×9959002657GFTSONATSOFTW6947EBGNG300212SHF00304044132506.HKRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Xunfei Healthcare Technology is the large dot.

Xunfei Healthcare Technology competitors and peer comparison

How Xunfei Healthcare Technology compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Xunfei Healthcare Technology against its 20 peers (data as of 18 Nov 2026)
Measure2506.HKPeer medianRank in peer set
1-month return+4.0%-5.3%5th highest of 21
6-month return-10.4%-11.8%10th highest of 21
Distance from 52-week high-39.9%-34.0%9th lowest of 21
Revenue growth (TTM)+24.7%+6.8%4th highest of 21
Operating margin-7.2%1.2%7th lowest of 21
Forward P/E343.4×25.9×most expensive of 12
ROIC minus cost of capital-13.7 pp-2.6 pp4th lowest of 20

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Xunfei Healthcare Technology 2506.HKHong Kong$674M-10%+25%-7%343.4×n/an/a
Ronglian 002642.SZChina$674M-21%+20%1%n/a36.2%-7.1%
Bestlink Technologies 603206.SSChina$667M-12%+10%1%n/a29.2%+9.9%
Linklogis 9959.HKHong Kong$688M+19%+24%-9%134.3×n/an/a
Sinodata 002657.SZChina$661M-35%-31%-33%185.6×n/an/a
Shanghai Rychen Technologies 301273.SZChina$660M+43%-6%-30%n/an/an/a
GFT Technologies GFT.DEGermany$692M+8%+6%6%14.6×-1.0%+14.8%
Beijing Join-Cheer Software 002279.SZChina$694M-26%-34%0%n/a39.5%-1.7%
Sonata Software SONATSOFTW.NSIndia$700M-12%+8%5%13.5×19.2%+20.4%
Zuken 6947.TJapan$712M+11%+15%15%19.1×-7.2%+8.4%
Vercom VRC.WAPoland$716M+1%+11%25%23.0×13.1%+32.2%
Gng Electronics EBGNG.NSIndia$631M+24%+34%11%25.9×n/an/a
Beijing E-Hualu Information Technology 300212.SZChina$631M-1%-23%-702%25.6×43.0%-29.0%
Yunnan Nantian Electronics Information 000948.SZChina$733M-13%-8%1%n/a14.9%+18.7%
Global Infotech 300465.SZChina$616M-36%-19%3%n/a38.5%-11.5%
SNP Schneider-Neureither & Partner SHF.DEGermany$741M+11%+13%16%27.6×3.9%+15.6%
Daheng New Epoch Technology 600288.SSChina$611M-35%-3%11%n/an/an/a
Shenzhen Sunwin Intelligent 300044.SZChina$601M-25%+116%-679%n/an/an/a
Beijing Philisense Technology 300287.SZChina$757M-21%-52%-25%n/an/an/a
Chutian Dragon 003040.SZChina$760M-22%-23%-7%35.5×n/an/a
baudroie,inc 4413.TJapan$595M+47%+49%18%28.6×8.6%+41.4%

Questions

Which companies are Xunfei Healthcare Technology's closest peers?
The cockpit's peer set: Ronglian (002642.SZ), Bestlink Technologies (603206.SS), Linklogis (9959.HK), Sinodata (002657.SZ), Shanghai Rychen Technologies (301273.SZ), GFT Technologies (GFT.DE), Beijing Join-Cheer Software (002279.SZ), Sonata Software (SONATSOFTW.NS).
Is Xunfei Healthcare Technology expensive compared with its peers?
On forward p/e it trades at 343.4× against a peer median of 25.9×, most expensive of 12 in its peer set.
How has Xunfei Healthcare Technology stock performed?
Over six months to 18 Nov 2026 the shares returned -10.4% against -11.8% for the median peer; over one year -19.2%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.